#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    VEXAS syndrome Transplant rejection Synovial sarcoma metastatic Myelodysplastic syndrome with excess blasts Prolymphocytic leukaemia Cholangiocarcinoma Neuroendocrine carcinoma metastatic Duchenne muscular dystrophy Monogenic diabetes Glycogen storage disease type II C3 glomerulopathy Facioscapulohumeral muscular dystrophy Biliary cancer metastatic Non-small cell lung cancer metastatic Pemphigoid More trials…

    Learn about Rare Diseases

    Bronchopulmonary dysplasia – Life with Disease Biotinidase deficiency Gaucher’s disease type I – Diagnostics Angiosarcoma metastatic – Trials in Disease Familial amyotrophic lateral sclerosis – Trials in Disease Von Willebrand’s disease – Basic Information Hyperoxaluria – Treatment Bronchopulmonary dysplasia – Basic Information Alport’s syndrome – Treatment Rett syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ALN-961583 177LU-PSMA-I&T Dsimc Tamsulosin Hydrochloride Kk8123 Imiquimod Iptacopan Insulin Human Metoprolol Succinate Brodalumab Cft1946 Bepranemab Davutamig Glucocorticoids Litifilimab Eclitasertib ARI0008 Piromelatine Teverelix Ucart22 More therapies…

    Learn about Your Condition

    Biliary adenoma Gout Liposarcoma Muscle injury Bronchiolitis Ophthalmoplegia Mitral valve incompetence Endocarditis bacterial Tertiary adrenal insufficiency Carotid artery stenosis Pyelonephritis acute Pneumococcal infection Rectosigmoid cancer Status epilepticus Pyoderma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Glofitamab and Drug Combination for Children and Young Adults with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Glofitamab
    • Ifosfamide
    • Obinutuzumab
    Czechia Denmark France Germany Hungary Italy +2

  • Study on the Effect of Ketoprofen and Drug Combination for Managing Pain After Heart Surgery in Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Nefopam
    • Tramadol
    • Sodium Chloride
    France

  • Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency Liver Disease and Mild Fibrosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Alpha-1 antitrypsin deficiency
    Investigated Drugs:
    • Fazirsiran
    • Saline
    Austria Belgium France Germany Ireland Italy +4

  • Study Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Carbasalate Calcium
    • Lactose Monohydrate
    • Givinostat
    Austria Bulgaria Croatia France Germany Hungary +5

  • Study on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1

    Recruiting

    4 1 1
    Investigated Drugs:
    • N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
    Austria Belgium Finland France Germany Italy +5

  • Study on Gabapentin for Treating Nerve Pain in the Leg from Lower Back Pain

    Recruiting

    3 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Gelatin
    • Gabapentin
    Denmark
Previous Page
1 … 457 458 459 460 461 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!